Chargement en cours...

HGG-26. DRAMATIC RESPONSE IN A CHILD TREATED FOR GLIOBLASTOMA WITH IMMUNE CHECK POINT INHIBITOR NIVOLUMAB

INTRODUCTION: Glioblastoma is not curable with current available therapies. Evidence has shown that tumours with a high mutational load can respond to immune check point inhibitors. PATIENT AND METHODS: We present the case of an 11 year old boy treated for intracranial malignant nerve sheet tumour a...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Dahl, Christine, Von Ottingen, Gorm, Laursen, Britt Elmedal, Lassen, Yasmin
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2018
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012745/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.298
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!